Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Phio Pharmaceuticals Corp. - Common Stock
(NQ:
PHIO
)
1.045
-0.005 (-0.48%)
Streaming Delayed Price
Updated: 10:42 AM EST, Dec 26, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Phio Pharmaceuticals Corp. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
Phio Pharmaceuticals Reports 2024 Year End Financial Results and Provides Business Update
March 31, 2025
Continues advancing clinical trial for INSTASYL siRNA lead product candidate PH-7623rd Cohort now fully enrolled in on-going clinical studyMarlborough, Massachusetts--(Newsfile...
Via
Newsfile
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical's Clinical Research at 2025 Annual Meeting
March 10, 2025
Marlborough, Massachusetts--(Newsfile Corp. - March 10, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
Phio Pharmaceuticals Announces Completion of Enrollment in Third Safety Cohort in PH-762 Phase 1b Dose-Escalation Study
March 05, 2025
Marlborough, Massachusetts--(Newsfile Corp. - March 5, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
February 26, 2025
Marlborough, Massachusetts--(Newsfile Corp. - February 26, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) a clinical-stage biotechnology company developing therapeutics that...
Via
Newsfile
What's Going On With Phio Pharmaceuticals Stock Today?
↗
January 14, 2025
Phio Pharmaceuticals stock drops 39.1% after announcing a $3.19 million direct offering and concurrent private placement.
Via
Benzinga
Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors
February 20, 2025
Marlborough, Massachusetts--(Newsfile Corp. - February 20, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
February 03, 2025
Marlborough, Massachusetts--(Newsfile Corp. - February 3, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
Phio Pharmaceuticals to Participate in the Renmark Financial Communications Virtual Non-Deal Roadshow Series
January 22, 2025
Marlborough, Massachusetts--(Newsfile Corp. - January 22, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 21, 2025
Raised approximately $12.08 million in gross proceeds since beginning of December 2024 Proceeds intended to be directed for development costs...
Via
Newsfile
Phio Pharmaceuticals Announces $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 16, 2025
Marlborough, Massachusetts--(Newsfile Corp. - January 16, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics...
Via
Newsfile
Topics
Regulatory Compliance
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
↗
January 15, 2025
Via
Benzinga
Phio Pharmaceuticals Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 15, 2025
Marlborough, Massachusetts--(Newsfile Corp. - January 15, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics...
Via
Newsfile
Topics
Regulatory Compliance
Dow Gains Over 200 Points; Signet Jewelers Shares Plunge
↗
January 14, 2025
Via
Benzinga
Topics
Stocks
We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run
↗
January 14, 2025
Around 34% foresee a pullback, while 13% are uncertain due to the stock's volatility.
Via
Stocktwits
Crude Oil Down 1%; Firefly Neuroscience Shares Spike Higher
↗
January 14, 2025
Via
Benzinga
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December
↗
January 14, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
January 14, 2025
Via
Benzinga
Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
January 14, 2025
Marlborough, Massachusetts--(Newsfile Corp. - January 14, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics...
Via
Newsfile
Topics
Regulatory Compliance
Why KB Home Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
↗
January 14, 2025
Via
Benzinga
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside
January 13, 2025
Via
AB Newswire
Topics
Regulatory Compliance
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge
↗
January 13, 2025
Via
Benzinga
Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On Monday - Here's Why
↗
January 13, 2025
Phio Pharmaceuticals reports promising Phase 1b trial results for PH-762, showing complete tumor clearance in two patients with no significant adverse effects.
Via
Benzinga
Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated
↗
January 13, 2025
CEO Robert Bitterman highlighted the potential of Phio’s proprietary INTASYL RNAi technology, which targets proteins that hinder the body’s immune response to cancer.
Via
Stocktwits
Crude Oil Surges 3%; Abercrombie & Fitch Shares Plunge
↗
January 13, 2025
Via
Benzinga
US Stocks Mixed; Nasdaq Down Over 1%
↗
January 13, 2025
Via
Benzinga
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762
January 13, 2025
Marlborough, Massachusetts--(Newsfile Corp. - January 13, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology
January 02, 2025
Marlborough, Massachusetts--(Newsfile Corp. - January 2, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics...
Via
Newsfile
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
December 23, 2024
Via
Benzinga
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 23, 2024
Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage biotechnology company that develops therapeutics...
Via
Newsfile
Topics
Regulatory Compliance
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket
↗
December 23, 2024
Shares of Rumble Inc.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
